RALPH V BOCCIA M.D.
NPI 1881663284
Internal Medicine - Hematology & Oncology in Bethesda, MD

Active since March 16, 2006PECOS EnrolledAccepts Medicare Assignment
73.57/100
CMS Quality Rating
6410 ROCKLEDGE DR, SUITE 660, BETHESDA, MD 20817(301) 571-0019(301) 571-0988 Get Directions Write a Review

NPPES record last updated: January 3, 2023. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Jan 3, 2023, Jul 2, 2021, May 21, 2020 and 1 more (4 updates tracked since 2020).

About Ralph V Boccia M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

RALPH V BOCCIA M.D. (NPI 1881663284) is an individual hematology & oncology provider in Bethesda, Maryland, licensed in Maryland (D29675) and active in the NPI registry since March 2006. He is enrolled in Medicare PECOS and is a graduate of University Of Minnesota Medical School (1977).

NPPES Registry Identity

NPI1881663284
Entity TypeIndividualMale
Primary Taxonomy207RH0003X
Provider Legal NameRALPH V BOCCIACredential: M.D.
Location Address6410 ROCKLEDGE DR, SUITE 660Bethesda, MD 20817-1809
Mailing AddressPo Box 749488Atlanta, GA 30374-9488 · (239) 432-8331 · Fax (813) 321-1296
Fax(301) 571-0988
Sole ProprietorNo
Medical School CMSUniversity Of Minnesota Medical SchoolGraduated 1977
Enumeration DateMarch 16, 2006
Last NPPES UpdateJanuary 3, 20234 updates tracked since enumeration
NPPES CertifiedJanuary 3, 2023
NPI 1881663284 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyInternal Medicine · Hematology & OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RH0003X
License Licensed in MD · D29675
Definition
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Also ListedInternal Medicine · Medical OncologyTaxonomy 207RX0202X · License D29675 (MD)
6410 ROCKLEDGE DR, Bethesda, MD 20817

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Ralph V Boccia M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID547347759
PECOS Enrollment IDI20110406000324
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 48

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, darbepoetin alfa, 1 microgram (non-esrd use) J0881
Darbepoetin alfa injection is a medication used to treat anemia (low red blood cell count) often caused by chronic kidney disease or chemotherapy. It works by stimulating your body to produce more red blood cells, helping to increase your energy and well-being.
120,500 services93 patients
Injection, ferric derisomaltose, 10 mg J1437
Ferric derisomaltose is an iron replacement product. It's given as an injection to treat iron deficiency anemia, a condition where the body lacks enough iron. The injection helps increase iron in your body to healthy levels.
24,000 services174 patients
Injection, daratumumab, 10 mg and hyaluronidase-fihj J9144
Daratumumab and hyaluronidase-fihj is an injection administered to treat certain types of blood cancer. The medication works by targeting and killing specific cancer cells. It's often given under the skin to reduce side effects and improve patient comfort.
20,880 services11 patients
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg J1569
The Gammagard Liquid injection is a type of immune globulin therapy. It's used to boost your body's immune system, helping it fight off infections. The therapy involves injecting a liquid form of proteins, collected from healthy donors, into your body. This is a 500mg dose.
18,412 services33 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
6,300 services51 patients
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 85025
A Complete Blood Cell Count is a common test that measures various components of the blood, including red cells (carry oxygen), white cells (fight infection), and platelets (help blood clot). An automated test ensures accuracy. The differential count provides detailed information about white cell types.
3,112 services736 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 20817 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$194.86 typical visit price
range $65.18 – $194.86
Typical copayment $48.71 (range $16.29 – $48.71)
Most-billed visit code 99205
Established Patient
$113.72 typical visit price
range $21.40 – $158.88
Typical copayment $28.43 (range $5.35 – $39.72)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

73.57/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality55.58
Promoting Interoperability98
Improvement Activities40
Cost50.92

Reported Quality Measures

Care Plan
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker…
87%814 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
92%6,751 patients4/55-star benchmark: 100%
Health Information Exchange
The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for…
8%53 patients1/55-star benchmark: 98%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
91%395 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Plan of Care for Pain
Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain
100%138 patients5/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
16%483 patients1/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
98%657 patients5/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
94%1,138 patients5/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients screenedForUse: 100% · 1,103 patients
Patients tobacco: 100% · 1,103 patients
100%43 patients5/55-star benchmark: 98%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
52%1,832 patients3/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
5%1,432 patients1/55-star benchmark: 79%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Occupational Therapist
6410 ROCKLEDGE DR, NRH REGIONAL REHAB - SUITE 600
BETHESDA, MD 20817
Acupuncturist
6410 ROCKLEDGE DR, SUITE 310
BETHESDA, MD 20817
Internal Medicine (Cardiovascular Disease)
6410 ROCKLEDGE DR, STE 200
BETHESDA, MD 20817
Internal Medicine (Medical Oncology)
6410 ROCKLEDGE DR, SUITE 660
BETHESDA, MD 20817
Speech-Language Pathologist
6410 ROCKLEDGE DR, NRH REGIONAL REHAB - SUITE 600
BETHESDA, MD 20817
Specialist/Technologist
6410 ROCKLEDGE DR, NRH REGIONAL REHAB - SUITE 600
BETHESDA, MD 20817
Physical Therapist
6410 ROCKLEDGE DR, NRH REGIONAL REHAB - SUITE 600
BETHESDA, MD 20817
Physical Therapist
6410 ROCKLEDGE DR, SUITE 301
BETHESDA, MD 20817

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Ralph Boccia's NPI number?

The NPI number for Ralph Boccia is 1881663284. It was assigned to this individual provider in the NPPES registry on March 16, 2006.

Where is Ralph Boccia located?

Ralph Boccia practices at 6410 Rockledge Dr Suite 660, Bethesda, MD 20817. The listed phone number is (301) 571-0019.

What is Ralph Boccia's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Hematology & Oncology, with taxonomy code 207RH0003X.

Is Ralph Boccia enrolled in Medicare?

Yes. Ralph Boccia is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Ralph Boccia was last updated on January 3, 2023. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 3 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.